Riyadh
Saudi Arabia · 1 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia, Riyadh | “Epidemiology and clinical outcomes of carbapenamase-producing organism (CPO) colonization: a tertiary care center experience in Saudi Arabia. While CRE epidemiology has been extensively studied worldwide, data on intestinal CRE colonization in Saudi Arabia remain limited. METHODS: A retrospective cohort study was conducted at King Abdulaziz Medical City (KAMC), Riyadh, Saudi Arabia. RESULTS: Among 6405 screened patients, 778 carbapenemase-producing isolates were detected (12.1%), OXA-48 was most prevalent (49.7%), followed by NDM (23.6%), OXA-48 + NDM co-producers (15.2%), KPC (4.8%), VIM (5.0%), and IMP-1 (1.7%).” | 0.95 | saudi_context_rules_v1 |